Rasagiline for amyotrophic lateral sclerosis: A randomized, controlled trial.
Jeffrey M StatlandDan MooreYunxia WangMaureen WalshTahseen MozaffarLauren ElmanSharon P NationsHiroshi MitsumotoJ Americo FernandesDavid SapersteinGhazala HayatLaura HerbelinChafic KaramJonathan KatzHeather M WilkinsAbdulbaki AgbasRussell H SwerdlowRegina M SantellaMazen M DimachkieRichard J Barohnnull nullPublished in: Muscle & nerve (2018)
Rasagiline did not alter disease progression compared with controls over 12 months of treatment. Muscle Nerve 59:201-207, 2019.